Company Directory > CRO > Tongze Hexin (Beijing) Medical Technology Co., Ltd.
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Tongze Hexin (Beijing) Medical Technology Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Tongze Hexin is a specialized Contract Research Organization (CRO) and regulatory consulting firm based in Beijing, China. The company focuses on the In Vitro Diagnostics (IVD) industry, providing comprehensive solutions including regulatory strategy, clinical trial management, quality management system (QMS) consulting, and innovation registration services for reagents, instruments, and software. They assist both domestic and international clients in navigating NMPA, FDA, CE, and WHO approval pathways. The company is known for its expertise in guiding innovative medical devices through special review procedures and maintaining high-quality standards for clinical and regulatory compliance.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:IVD Regulatory & Clinical Consulting
SIZE & FINANCIALS
Employees:51-200
Founded:2017
Ownership:private
Status:operating
0
CORPORATE STRUCTURE
Key Partnerships:Various IVD manufacturers (e.g., BGI, Wondfo, and other diagnostic kit developers)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Brian Yang - CEO
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Tongze Hexin (Beijing) Medical Technology Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.